
Lindsay Anne (Magura) Rein MD
Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-684-8111
Dr. Rein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
- Duke University HospitalResidency, Internal Medicine, 2008 - 2011
- University of North Dakota School of Medicine and Health SciencesClass of 2008
Certifications & Licensure
- NC State Medical License 2008 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Mastocytosis: Part I: Pathogenesis, Clinical Presentation and Classification.J Alexander Sizemore, Stefan Hansen, Caitlin A Moran, Amy J Petty, Lindsay A M Rein
Journal of the American Academy of Dermatology. 2025-06-19 - Mastocytosis: Part II: Diagnosis and Management of Mastocytosis through a Multidisciplinary Lens.Caitlin A Moran, Amy J Petty, J Alexander Sizemore, Stefan Hansen, Lindsay A M Rein
Journal of the American Academy of Dermatology. 2025-06-19 - β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma.Parker Mathews, Xiaobei Wang, Jian Wu, Shaima Jabbar, Kimberly Burcher
Cells. 2025-03-26
Press Mentions
- SUMMIT Results: Bezuclastinib in Non-Advanced Systemic MastocytosisApril 3rd, 2025
- What's Your Approach? Treating MyelofibrosisAugust 7th, 2024
- OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesApril 25th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: